Highly variable drug product [PK / PD]

posted by luvblooms  – India, 2013-02-06 13:27 (4533 d 21:02 ago) – Posting: # 9976
Views: 8,852

Dear Jag
My experience
For simple IR products
BCS class-1 and III: very less (~none, only shock we gor once was for BUSPIRONE where Intra subject CV was 38% and inter subject CV was 80%)
BCS class-II and IV: ~50% case (mainly beause of variable ingredient effects, manufacturing process, variable rate and extentof absorption etc etc)

For MR/ER/PR products
Variability was observed in ~50 percent case inter-subject variability was higher mainly because of he design of test product.

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,681 registered users;
42 visitors (0 registered, 42 guests [including 11 identified bots]).
Forum time: 11:29 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5